Beranda › Mieloma Multipel › Arizona › Gilbert
Uji klinis Mieloma Multipel di Gilbert, AZ
6 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Gilbert (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Menerima pesertaFase 3
- Research Site, Gilbert
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
- Banner MD Anderson Cancer Center, Gilbert
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- Banner MD Anderson Cancer Center, Gilbert
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Menerima pesertaFase 3
- Research Site, Gilbert
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Menerima pesertaFase 1
- Banner MD Anderson Cancer Center, Gilbert
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Banner MD Anderson, Gilbert
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Studi lain di Gilbert
- Kanker Paru Non-Sel Kecil12 studi
- Kanker Kolorektal9 studi
- Kanker Payudara9 studi
- Kanker Paru8 studi
- Kanker (semua jenis)8 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Kanker Metastatik6 studi
- Gagal Jantung6 studi
- Penyakit Kardiovaskular6 studi
- Kanker Kandung Kemih6 studi
- Limfoma Non-Hodgkin5 studi
- Limfoma Sel B Besar Difus5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.